secwatch / observer
8-K filed March 4, 2026, 6:59 PM ET ticker TVGN CIK 0001860871
other material confidence high sentiment neutral materiality 0.70

Tevogen Bio announces 1-for-50 reverse stock split effective March 6, 2026 to regain Nasdaq compliance

Tevogen Bio Holdings Inc.

item 3.03item 5.03item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-26-008786
form_type
8-K
ticker
TVGN
cik
0001860871
company_name
Tevogen Bio Holdings Inc.
filed_at
2026-03-04T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.590936+00:00
generated_at
2026-05-15T21:49:23.554770+00:00
sec_items
["3.03", "5.03", "7.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.7
calibrated_materiality_score
0.7
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-26-008786
json_url
https://secwatch.observer/filing/0001493152-26-008786.json
markdown_url
https://secwatch.observer/filing/0001493152-26-008786.md
text_url
https://secwatch.observer/filing/0001493152-26-008786.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/form8-k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

189c504cb95c01ff7e449b7d59552998297819a7

Tevogen Bio Holdings Inc.: Effected a 1-for-50 reverse stock split by filing a Certificate of Amendment to the Certificate of Incorporation, effective March 6, 2026 (effective 2026-03-06).

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

WAMFF

Alaska Silver simplifies capital structure, eliminates dual-class shares

Alaska Silver Corp. May 7, 2026, 7:59 PM ET other_material Items 3.03, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the "Company"), approved an amendment (the "Amendment") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of "Common Shares," no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.

Filing page SEC filing

CUK

Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary

CARNIVAL PLC May 7, 2026, 7:59 PM ET other_material Items 1.02, 2.01, 3.01, 3.02, 3.03, 5.01, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to "Carnival Corporation Ltd." (the "Redomiciliation" and, together with the DLC Unification, the "DLC Unification and Redomiciliation Transactions").

Filing page SEC filing

ENZN

Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%

Viskase Holdings, Inc. May 5, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.

Filing page SEC filing

CWEN

Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C

Clearway Energy, Inc. May 1, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 5.07, 7.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

BNZI

Banzai announces 1-for-20 reverse stock split effective May 8, 2026 to maintain Nasdaq compliance

Banzai International, Inc. May 6, 2026, 7:59 PM ET other_material Items 3.03, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

On April 28, 2026, the Company filed a Certificate of Amendment to its COI with the Secretary of State of Delaware (the “Certificate of Amendment”), for the Reverse Stock Split at a ratio of 1-for-20.

Filing page SEC filing

MTNE

CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE

CH4 Natural Solutions Corp May 5, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.

Filing page SEC filing

AAWH

Ascend Wellness Holdings completes Class B conversion and annual meeting

Ascend Wellness Holdings, Inc. May 5, 2026, 7:59 PM ET other_material Items 3.03, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 3.03, 5.03, 9.01 same event type: other_material similar materiality

This filing

On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).

Comparable filing

On May 5, 2026, the Company filed a Certificate of Retirement with the Secretary of State of the State of Delaware (the “Certificate of Retirement”) to effect the retirement of the 65,000 shares of Class B Common Stock that were issued but no longer outstanding following the Conversion. Pursuant to Section 243(b) of the DGCL, upon its effectiveness, the Certificate of Retirement had the effect of amending the Certificate of Incorporation to reduce the total number of authorized shares of common stock of the Company by 65,000, to 750,035,000, and to reduce the number of authorized shares of Class B Common Stock by 65,000, to 35,000.

Filing page SEC filing

Source: SEC EDGAR
accession 0001493152-26-008786
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.